/
Description of the Business and Background LivaNova PLC is a market-leading global medical technology company. The Company designs, develops, manufactures, markets, and sells products, therapies, and services that are consistent with LivaNova s mission to create ingenious medical solutions that ignite patient turnarounds.
14.36% operating margin is respectable but not wide. ROIC at 9.79%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 10.7% YoY with margins expanding 4.1pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$1.43B
▲ +10.7% YoY
Net Income (TTM)
$107M
▼ -483.5% YoY
Op. Margin
13.41%
▲ +4.1pp YoY
ROIC
11.06%
▲ +4.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$161M
▲ +27.5% YoY
Op. Cash Flow (TTM)
$246M
▲ +39.0% YoY
Net Debt
-$199M
Net Cash Position
Cash & Equiv.
$540M
5Y CAGR: +8.2%
Continue Research